US Launch Of GRAFAPEX Will Provide Seven Years Of Exclusive Market Access

AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Published
19 Feb 25
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
CA$6.50
59.1% undervalued intrinsic discount
31 Jul
CA$2.66
Loading
1Y
16.7%
7D
-6.3%

Author's Valuation

CA$6.5

59.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 2.20%

Shared on23 Apr 25
Fair value Decreased 0.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Increased 2.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 0.94%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 1.61%

AnalystConsensusTarget has decreased revenue growth from 9.4% to 8.1%, decreased profit margin from 18.6% to 16.7% and increased future PE multiple from 7.9x to 9.0x.

Shared on13 Mar 25